| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.6 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |